ISoP Sky Background

International Society of Pharmacovigilance


At the forefront of Pharmacovigilance around the world

BECOME A MEMBER

What is ISoP?

The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…

ISoP 2017

ISOP Liverpool 2017

Annual Meeting

ACC, Liverpool, 15-18 October 2017 “Pharmacovigilance in the 21st Century” Register Now!
ISoP 2017 Liverpool

ISoP Training

Mid Year Training

Canberra, Australia, 15-16 March 2018
Pharmacovigilance in the Western Pacific:
Global approaches to risk-management of medicines.

ISoP-Mid Year 2017 Bangkok

ISoP ETP

Education Training Programme

Education Training Programme
A primary objective of ISoP is to promote the safest use of drugs through contributing to appropriate education. Educational Training Link

ISoP Seminar
Boston, USA

4-5 December 2017

Intelligent Automation in PharmacovigilanceMORE INFORMATION

What’s New

Obituary

We are deeply saddened to report the death of Professor Giampaolo Velo past ISoP President (2003-2006)

PV Professional Qualification Framework Group

More information, click here

The New Phase of ISoP

Article published in Drug Safety

Herbal and Traditional Medicines Group

More information, click here

EMA Communication

PRAC recommends modified-release paracetamol be removed from market

New ISoP Statutes

Click here

ISoP Latest

ISoP @ISoPonline
Oct 16
ISoP2017 has taken off beautifully https://t.co/dpiHXesWtp
ISoP @ISoPonline
Oct 11
This happens in Liverpool next week. Still time to register https://t.co/9KuvkXD1PY https://t.co/jlZt7dAciN

Sten Olsson
President ISoP

President of ISoP

ISoP is becoming a mature organization, having gone through generations of development since the early 1990s, and is right now entering into a new phase.

READ MORE

Drug Safety

ISoP Official Journal

READ MORE

Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.